Dyadic Attends Investor Events in December
JUPITER, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be attending the following investor events during the month of December:
Related news for (DYAI)
- Today’s Top Performers: MoBot’s Market Review 07/23/25 07:00 PM
- Breaking News: MoBot’s Latest Update as of 07/23/25 06:00 PM
- Today’s Top Performers: MoBot’s Market Review 07/23/25 05:00 PM
- Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
- Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference